Article
Epigenetic modulators as therapeutic targets in prostate cancer
15 Sept 2016
Abstract excerpt
Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/or expression of the epigenetic machinery, affecting the expression of several important genes. Remarkably,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
